Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Short term Debt (2016 - 2024)

Historic Short term Debt for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $8.3 billion.

  • Sanofi's Short term Debt fell 1681.7% to $8.3 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $8.3 billion, marking a year-over-year decrease of 1681.7%. This contributed to the annual value of $4.5 billion for FY2024, which is 10332.23% up from last year.
  • As of Q2 2025, Sanofi's Short term Debt stood at $8.3 billion, which was down 1681.7% from $4.5 billion recorded in Q4 2024.
  • Sanofi's Short term Debt's 5-year high stood at $9.9 billion during Q2 2024, with a 5-year trough of $2.2 billion in Q4 2023.
  • Moreover, its 5-year median value for Short term Debt was $4.3 billion (2022), whereas its average is $4.9 billion.
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 4833.18% in 2023, then soared by 10441.41% in 2024.
  • Quarter analysis of 5 years shows Sanofi's Short term Debt stood at $3.6 billion in 2021, then grew by 16.95% to $4.3 billion in 2022, then tumbled by 48.33% to $2.2 billion in 2023, then soared by 104.41% to $4.5 billion in 2024, then soared by 83.95% to $8.3 billion in 2025.
  • Its Short term Debt was $8.3 billion in Q2 2025, compared to $4.5 billion in Q4 2024 and $9.9 billion in Q2 2024.